Literature DB >> 1176145

Sulfatide excreting heterozygous carrier of juvenile metachromatic leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy.

K Harzer, A S Recke.   

Abstract

In a family with juvenile metachromatic leukodystrophy (sulfatide lipidosis) 2 patients showed residual arysulfatase A activities of 5--6%. The patients' healthy father was characterized biochemically by a 39% normal activity of leukocyte plus plasma arylsulfatase A. The father was further characterized by a high sulfatide excretion (0.2--0.5 mg/I urine) and, paradoxically, by a normal sulfatide degrading enzyme activity in vitro. This special carrier is suspected to be heterozygous for a) arylsulfatase A deficiency and b) arylsulfatase A (sulfatidase) lability. This presumed additional genetic defect could be the cause of the sulfatide excretion which, in turn, would be a sign of the preclinical stage of an exceptional form of adult metachromatic leukodystrophy. The normal sulfatidase activity seems to be due to an in vitro effect.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176145     DOI: 10.1007/bf00394192

Source DB:  PubMed          Journal:  Humangenetik        ISSN: 0018-7348


  11 in total

1.  A CONTROLLED STUDY OF ENZYMIC ACTIVITIES IN THREE HUMAN DISORDERS OF GLYCOLIPID METABOLISM.

Authors:  J H AUSTIN; A S BALASUBRAMANIAN; T N PATTABIRAMAN; S SARASWATHI; D K BASU; B K BACHHAWAT
Journal:  J Neurochem       Date:  1963-12       Impact factor: 5.372

2.  EVIDENCE FOR THE GENETIC BLOCK IN METACHROMATIC LEUCODYSTROPHY (ML).

Authors:  E MEHL; H JATZKEWITZ
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

3.  The assay of arylsulphatases A and B in human urine.

Authors:  H BAUM; K S DODGSON; B SPENCER
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

4.  Juvenile metachromatic leukodystrophy: deficiency of an arylsufatase A component.

Authors:  Y Suzuki; Y Mizuno
Journal:  J Pediatr       Date:  1974-12       Impact factor: 4.406

5.  An activator of cerebroside sulphatase in human normal liver and in cases of congenital metachromatic leukodystrophy.

Authors:  H Jatzkewitz; K Stinshoff
Journal:  FEBS Lett       Date:  1973-05-15       Impact factor: 4.124

6.  [Quantitative metachromasia with pseudoisocyanin: a new method for the determination of sulphatides, and for use in the diagnosis of metachromatic leucodystrophy (sulphatide lipidosis) (author's transl)].

Authors:  K Harzer; H U Benz
Journal:  Z Klin Chem Klin Biochem       Date:  1973-11

7.  The patterns of arylsulphatases A and B in human normal and metachromatic leucodystrophy tissues and their relationship to the cerebroside sulphatase activity.

Authors:  K Harzer; K Stinshoff; W Mraz; H Jatzkewitz
Journal:  J Neurochem       Date:  1973-02       Impact factor: 5.372

8.  A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy.

Authors:  M T Porter; A L Fluharty; J Trammell; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1971-08-06       Impact factor: 3.575

9.  Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood.

Authors:  J P Kampine; R O Brady; J N Kanfer; M Feld; D Shapiro
Journal:  Science       Date:  1967-01-06       Impact factor: 47.728

10.  Metachromatic leukodystrophy (MLD). IX. Qualitative and quantitative differences in urinary arylsulfatase A in different forms of MLD.

Authors:  D Stumpf; J Austin
Journal:  Arch Neurol       Date:  1971-02
View more
  1 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.